SNOA: Sonoma Pharmaceuticals, Inc. Stock

by  •  • Comments Off on SNOA: Sonoma Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 2.47
Enterprise Value ($M) 0.10
Book Value ($M) 6.69
Book Value / Share 0.43
Price / Book 0.37
NCAV ($M) 4.58
NCAV / Share 0.29
Price / NCAV 0.54

Profitability (mra)
Return on Invested Capital (ROIC) -0.72
Return on Assets (ROA) -0.31
Return on Equity (ROE) -0.64

Liquidity (mrq)
Quick Ratio 3.11
Current Ratio 4.07

Balance Sheet (mrq) ($M)
Current Assets 12.50
Assets 14.62
Liabilities 7.93
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT T
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SEC
2023-06-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-24 26,332 114,671 22.96
2024-04-23 17,219 148,720 11.58
2024-04-22 47,051 91,318 51.52
2024-04-19 51,380 13,933 368.76

(click for more detail)

Similar Companies
SMFL – Smart for Life, Inc. SNDL – SNDL Inc.
SNGX – Soligenix, Inc. SNPX – Synaptogenix, Inc.
SNTI – Senti Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io